Dámaso Molero, appointed member of the Technical Committee of the Interdepartmental Commission for Personalized Medicine of Navarra.
News and updates
Press Releases
ANLBIO selected Biovian for manufacturing of AAV-based product for the treatment of Alzheimer’s disease.
Elena Erroba, winner of the Navarra 2021 Management Award organised by AMEDNA-NEEZE
3P Biopharmaceuticals presents its growth plan at BIOSPAIN to further expand its operations in Europe and the USA
3P Biopharmaceuticals enters into alliance with Precirix to develop precision radiopharmaceuticals in oncology
3P Biopharmaceuticals receives FDA approval
Lokon Pharma AB signs an agreement with Biovian
3P Biopharmaceuticals and Buzzard Pharmaceuticals start a cGMP manufacturing collaboration to develop a new treatment to combat solid tumours
Working in biotechnology means working to improve the planet and people’s lives
Tenboron Ltd signs an agreement with Biovian for GMP contract manufacturing of a novel boron carrier for treating solid tumors
Eurocine Vaccines initiates process development of the vaccine candidate against chlamydia
The University of Navarra and the company 3P Biopharmaceuticals will promote research and talent management in technology and the production of new drugs.
Annexin and Biovian have successfully completed ANXV manufacturing
Affibody AB has selected Biovian as a CDMO partner for their novel therapeutic protein candidate, ABY-062.
Eurocine Vaccines has selected Biovian as contract developer for the chlamydia vaccine candidate
3P Biopharmaceuticals and Invizius hope for reducing the cardiovascular complications associated with dialysis